Treatment with quercetin and 3′,4′-dihydroxyflavonol inhibits platelet function and reduces thrombus formation in vivo

Journal of Thrombosis and Thrombolysis

Volumn 36, Issue 1, 2013, Pages 50-57

  Mosawy, S ^a   Jackson, D E ^a   Woodman, O L ^a   Linden, M D ^a,b  

^a RMIT UNIVERSITY   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Arterial thrombosis; Flavonols; Platelet function; Platelet inhibition; Platelets

Indexed keywords

3',4' DIHYDROXYFLAVONOL; EPTIFIBATIDE; FLAVONOL; QUERCETIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTITHROMBOTIC ACTIVITY; AREA UNDER THE CURVE; ARTERY THROMBOSIS; ARTICLE; BLOOD CLOTTING; BLOOD VESSEL OCCLUSION; CAROTID ARTERY FLOW; CONTROLLED STUDY; DRUG MECHANISM; EXOCYTOSIS; FEMALE; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION;

ANIMALS; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; EXOCYTOSIS; FEMALE; FLAVONOLS; MALE; MICE; PLATELET AGGREGATION; QUERCETIN; THROMBOSIS; TIME FACTORS;

EID: 84879205608     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-012-0827-2     Document Type: Article

References (41)

1. Michelson AD (2010) Antiplatelet therapies for the treatment of cardiovascular disease. Nat Rev Drug Discov 9(2):154-169
2. Willoughby S, Holmes A, Loscalzo J (2002) Platelets and cardiovascular disease. Eur J Cardiovasc Nurs 1(4):273-288
3. Anjaneyulu M, Chopra K (2004) Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol 31(4):244-248
4. Engler MB, Engler MM (2006) The emerging role of flavonoid-rich cocoa and chocolate in cardiovascular health and disease. Nutr Rev 64(3):109-118
5. McCullough ML, Peterson JJ, Patel R, Jacques PF, Shah R, Dwyer JT (2012) Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. Am J Clin Nutr 95(2):454-464
6. Geleijnse JM, Launer LJ, Van der Kuip DA, Hofman A, Witteman JC (2002) Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Am J Clin Nutr 75(5):880-886
7. Beretz A, Cazenave JP, Anton R (1982) Inhibition of aggregation and secretion of human platelets by quercetin and other flavonoids: structure-activity relationships. Agents Actions 12(3):382-387
8. Pietta PG (2000) Flavonoids as antioxidants. J Nat Prod 63(7):1035-1042
9. Rechner AR, Kroner C (2005) Anthocyanins and colonic metabolites of dietary polyphenols inhibit platelet function. Thromb Res 116(4):327-334
10. Hubbard GP, Wolffram S, Lovegrove JA, Gibbins JM (2004) Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans. J Thromb Haemost 2(12):2138-2145
11. Chong MF, Macdonald R, Lovegrove JA (2010) Fruit polyphenols and CVD risk: a review of human intervention studies. Br J Nutr 104(Suppl 3):S28-S39
12. Vitseva O, Varghese S, Chakrabarti S, Folts JD, Freedman JE (2005) Grape seed and skin extracts inhibit platelet function and release of reactive oxygen intermediates. J Cardiovasc Pharmacol 46(4):445-451
13. Freedman JE, Parker C 3rd, Li L, Perlman JA, Frei B, Ivanov V, Deak LR, Iafrati MD, Folts JD (2001) Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation 103(23):2792-2798
14. Briggs WH, Folts JD, Osman HE, Goldman IL (2001) Administration of raw onion inhibits platelet-mediated thrombosis in dogs. J Nutr 131(10):2619-2622
15. Jasuja R, Passam FH, Kennedy DR, Kim SH, van Hessem L, Lin L, Bowley SR, Joshi SS, Dilks JR, Furie B, Furie BC, Flaumenhaft R (2012) Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents. J Clin Invest 122(6):2104-2113
16. Perez-Vizcaino F, Duarte J (2010) Flavonols and cardiovascular disease. Mol Aspects Med 31(6):478-494
17. Duarte J, Perez-Vizcaino F, Zarzuelo A, Jimenez J, Tamargo J (1993) Vasodilator effects of quercetin in isolated rat vascular smooth muscle. Eur J Pharmacol 239(1-3):1-7
18. Perez-Vizcaino F, Ibarra M, Cogolludo AL, Duarte J, Zaragoza-Arnaez F, Moreno L, Lopez-Lopez G, Tamargo J (2002) Endothelium-independent vasodilator effects of the flavonoid quercetin and its methylated metabolites in rat conductance and resistance arteries. J Pharmacol Exp Ther 302(1):66-72
19. Woodman OL, Meeker WF, Boujaoude M (2005) Vasorelaxant and antioxidant activity of flavonols and flavones: structure-activity relationships. J Cardiovasc Pharmacol 46(3):302-309
20. Woodman OL, Chan E (2004) Vascular and anti-oxidant actions of flavonols and flavones. Clin Exp Pharmacol Physiol 31(11):786-790
21. Kim HY, Seok YM, Woodman OL, Williams SJ, Kim IK (2011) 3′,4′-Dihydroxyflavonol reduces vascular contraction through Ca(2 +) desensitization in permeabilized rat mesenteric artery. Naunyn Schmiedebergs Arch Pharmacol 385(2):191-202
22. Chan EC, Drummond GR, Woodman OL (2003) 3′,4′- dihydroxyflavonol enhances nitric oxide bioavailability and improves vascular function after ischemia and reperfusion injury in the rat. J Cardiovasc Pharmacol 42(6):727-735
23. Wang S, Thomas CJ, Dusting GJ, Woodman OL, May CN (2009) 3′,4′-Dihydroxyflavonol improves post-ischaemic coronary endothelial function following 7 days reperfusion in sheep. Eur J Pharmacol 624(1-3):31-37
24. Orlowski E, Chand R, Yip J, Wong C, Goschnick MW, Wright MD, Ashman LK, Jackson DE (2009) A platelet tetraspanin superfamily member, CD151, is required for regulation of thrombus growth and stability in vivo. J Thromb Haemost 7(12):2074-2084
25. Goschnick MW, Lau LM, Wee JL, Liu YS, Hogarth PM, Robb LM, Hickey MJ, Wright MD, Jackson DE (2006) Impaired "outside-in" integrin alphaIIbbeta3 signaling and thrombus stability in TSSC6-deficient mice. Blood 108(6):1911-1918
26. Linden MD, Frelinger AL 3rd, Barnard MR, Przyklenk K, Furman MI, Michelson AD (2004) Application of flow cytometry to platelet disorders. Semin Thromb Hemost 30(5):501-511
27. Kinlough-Rathbone RL, Packham MA, Reimers HJ, Cazenave JP, Mustard JF (1977) Mechanisms of platelet shape change, aggregation, and release induced by collagen, thrombin, or A23,187. J Lab Clin Med 90(4):707-719
28. Jackson SP (2007) The growing complexity of platelet aggregation. Blood 109(12):5087-5095
29. Woollard KJ, Sturgeon S, Chin-Dusting JP, Salem HH, Jackson SP (2009) Erythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injury. J Biol Chem 284(19):13110-13118
30. Leo CH, Hart JL, Woodman OL (2011) 3′,4′-Dihydroxyflavonol reduces superoxide and improves nitric oxide function in diabetic rat mesenteric arteries. PLoS ONE 6(6):e20813
31. Schramm DD, Wang JF, Holt RR, Ensunsa JL, Gonsalves JL, Lazarus SA, Schmitz HH, German JB, Keen CL (2001) Chocolate procyanidins decrease the leukotriene-prostacyclin ratio in humans and human aortic endothelial cells. Am J Clin Nutr 73(1):36-40
32. Polagruto JA, Schramm DD, Wang-Polagruto JF, Lee L, Keen CL (2003) Effects of flavonoid-rich beverages on prostacyclin synthesis in humans and human aortic endothelial cells: association with ex vivo platelet function. J Med Food 6(4):301-308
33. Ishizawa K, Izawa-Ishizawa Y, Ohnishi S, Motobayashi Y, Kawazoe K, Hamano S, Tsuchiya K, Tomita S, Minakuchi K, Tamaki T (2009) Quercetin glucuronide inhibits cell migration and proliferation by platelet-derived growth factor in vascular smooth muscle cells. J Pharmacol Sci 109(2):257-264
34. Ren Q, Ye S, Whiteheart SW (2008) The platelet release reaction: just when you thought platelet secretion was simple. Curr Opin Hematol 15(5):537-541
35. Rinder CS, Student LA, Bonan JL, Rinder HM, Smith BR (1993) Aspirin does not inhibit adenosine diphosphate-induced platelet alpha-granule release. Blood 82(2):505-512
36. Italiano JE Jr, Richardson JL, Patel-Hett S, Battinelli E, Zaslavsky A, Short S, Ryeom S, Folkman J, Klement GL (2008) Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 111(3):1227-1233
37. van Nispen tot Pannerden H, de Haas F, Geerts W, Posthuma G, van Dijk S, Heijnen HF (2010) The platelet interior revisited: electron tomography reveals tubular alpha-granule subtypes. Blood 116 (7):1147-1156
38. Radtke J, Linseisen J, Wolfram G (2002) Fasting plasma concentrations of selected flavonoids as markers of their ordinary dietary intake. Eur J Nutr 41(5):203-209
39. Siess MH, Vernevaut MF (1982) The influence of food flavonoids on the activity of some hepatic microsomal monooxygenases in rats. Food Chem Toxicol 20(6):883-886
40. Harwood M, Danielewska-Nikiel B, Borzelleca JF, Flamm GW, Williams GM, Lines TC (2007) A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem Toxicol 45(11):2179-2205
41. Manach C, Williamson G, Morand C, Scalbert A, Remesy C (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81(1 suppl):230S-242S